stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs Phibro Animal Health Corporation (PAHC)
- Amphastar Pharmaceuticals, Inc. AMPH 27.59 −1.53%
- Phibro Animal Health Corporation PAHC 35.54 −9.87%
Amphastar Pharmaceuticals, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Phibro Animal Health Corporation is the larger, with a market value of $1.4B against $1.2B — 1.2× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 12.3× against 14.0×. Phibro Animal Health Corporation grew revenue faster over the last twelve months: 10.1% against 3.11%. Amphastar Pharmaceuticals, Inc. has the higher net margin (13.3% vs 6.67%) and the lower return on invested capital (6.12% vs 11.3%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 14 and Phibro Animal Health Corporation on 8.
Valuation
Profitability
| Metric | AMPH | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 33.83% | 53.51% |
| Operating margin | 18.74% | 12.51% | 0.00% |
| Net margin | 13.27% | 6.67% | (2.45%) |
| Free cash flow margin | 18.64% | 1.41% | 0.00% |
| Return on equity | 12.44% | 28.17% | (0.80%) |
| Return on assets | 5.86% | 7.08% | (1.67%) |
| Return on invested capital | 6.12% | 11.27% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack